Table 2 from Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer

অনুরূপ উপাদানগুলি

• Figure 2 from Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
  অনুযায়ী: Robert Wesolowski (8863505)
  প্রকাশিত: (2025)
• Figure 1 from Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
  অনুযায়ী: Robert Wesolowski (8863505)
  প্রকাশিত: (2025)
• Table 1 from Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
  অনুযায়ী: Robert Wesolowski (8863505)
  প্রকাশিত: (2025)
• Table 3 from Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
  অনুযায়ী: Robert Wesolowski (8863505)
  প্রকাশিত: (2025)
• Table 4 from Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
  অনুযায়ী: Robert Wesolowski (8863505)
  প্রকাশিত: (2025)